Ameriprise
AGL icon

Ameriprise’s Agilon Health AGL Stock Holding History

Ameriprise’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,941
Closed -$210K – 3960
2025
Q1 		$210K Buy
1,941
+285
+17% +$24.8K ﹤0.01% 3777
2024
Q4 		$78.6K Buy
+1,656
New +$100K ﹤0.01% 3976
2024
Q3 		– Sell
-512
Closed -$83.6K – 3926
2024
Q2 		$83.6K Buy
+512
New +$72.9K ﹤0.01% 3787
2023
Q1 		– Sell
-3,226
Closed -$1.3M – 3935
2022
Q4 		$1.3M Sell
3,226
-198
-6% -$92.9K ﹤0.01% 3007
2022
Q3 		$2M Buy
3,424
+3
+0.1% +$1.8K ﹤0.01% 2780
2022
Q2 		$1.87M Buy
+3,421
New +$1.73M ﹤0.01% 2835

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Ameriprise's AGL Position: Q2 2025 in Review

Ameriprise sold out of Agilon Health (AGL) in Q2 2025, closing a stake of 1,941 shares — an estimated $210K sold.

Ameriprise first reported a position in AGL in Q2 2022 and held it in 6 quarters. The position peaked at $2M in Q3 2022. 205 funds tracked by Wall St. Rank hold AGL as of Q2 2025.

  • Ameriprise reported no remaining Agilon Health position as of Q2 2025 after selling out during the quarter.
  • Ameriprise sold 1,941 Agilon Health shares in Q2 2025, an estimated $210K.
  • Ameriprise first reported a position in Agilon Health in Q2 2022 and held it in 6 quarters.
  • Ameriprise's Agilon Health position peaked at $2M in Q3 2022.
  • 205 funds tracked by Wall St. Rank held Agilon Health as of Q2 2025.

Based on Ameriprise's 13F filing for Q2 2025, filed 14 Aug 2025.